Neuroderm Ltd (NDRM) Reaches $29.00 After 4.00% Down Move; Chanticleer Holdings Has 1 Sentiment

July 3, 2017 - By Clifton Ray

The stock of Neuroderm Ltd (NASDAQ:NDRM) is a huge mover today! About 86,689 shares traded. Neuroderm Ltd (NASDAQ:NDRM) has risen 27.60% since July 3, 2016 and is uptrending. It has outperformed by 10.90% the S&P500.The move comes after 6 months negative chart setup for the $782.12M company. It was reported on Jul, 3 by Barchart.com. We have $27.84 PT which if reached, will make NASDAQ:NDRM worth $31.28M less.

Chanticleer Holdings, Inc. is engaged in the business of owning, operating and franchising fast casual dining concepts domestically and internationally. The company has market cap of $7.97 million. The Company’s brands include Hooters, American Burger Company , BGR: the Burger Joint (BGR), BT’s Burger Joint (BT), Little Big Burger (LBB) and Just Fresh. It currently has negative earnings. Hooters restaurants are casual beach-themed establishments featuring music, sports on large flat screens, and a menu that includes seafood, burgers, salads and Hooters original chicken wings.

NeuroDerm Ltd. is an Israel-based clinical-stage pharmaceutical company. The company has market cap of $782.12 million. The Firm is engaged in developing treatments for central nervous system disorders, primarily Parkinson’s disease, as well as other CNS diseases. It currently has negative earnings. The Company’s Parkinson’s disease product candidates are drug-device combination products, with devices and varying levodopa (LD)/carbidopa (CD) or apomorphine concentrations and dosages.

Among 5 analysts covering NeuroDerm (NASDAQ:NDRM), 5 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. NeuroDerm had 10 analyst reports since August 6, 2015 according to SRatingsIntel. The stock of Neuroderm Ltd (NASDAQ:NDRM) has “Outperform” rating given on Wednesday, November 11 by Raymond James. The firm has “Buy” rating by Jefferies given on Friday, December 9. On Monday, August 10 the stock rating was upgraded by Zacks to “Hold”. On Thursday, August 6 the stock rating was maintained by Roth Capital with “Buy”. The stock has “Outperform” rating by Oppenheimer on Wednesday, June 14. The stock of Neuroderm Ltd (NASDAQ:NDRM) earned “Buy” rating by TH Capital on Thursday, August 6. Jefferies maintained Neuroderm Ltd (NASDAQ:NDRM) on Friday, August 14 with “Buy” rating. Oppenheimer maintained the shares of NDRM in report on Tuesday, August 11 with “Outperform” rating. The rating was downgraded by Oppenheimer to “Perform” on Tuesday, March 7.

Intersect Capital Llc holds 0.04% of its portfolio in Chanticleer Holdings Inc for 123,783 shares. Eidelman Virant Capital owns 129,790 shares or 0.03% of their US portfolio. Moreover, Gilman Hill Asset Management Llc has 0.01% invested in the company for 59,890 shares. The Virginia-based Thompson Davis & Co. Inc. has invested 0.01% in the stock. Bank Of America Corp De, a North Carolina-based fund reported 42,830 shares.

Since January 1, 0001, it had 4 insider buys, and 0 selling transactions for $15,688 activity.

About 819 shares traded. Chanticleer Holdings Inc (HOTR) has declined 43.12% since July 3, 2016 and is downtrending. It has underperformed by 59.82% the S&P500.